Skip to main content
. 2020 Nov 2;20(12):1–134.

Table 4:

Results of Economic Literature Review—Summary

Resultsa
Author, Year, Country of Publication Analytic Technique, Study Design, Perspective, Time Horizon Population Intervention and Comparator Health Outcomes Costs Cost-Effectiveness (Home vs. outpatient clinic)
Koek et al, 201052

The Netherlands

  • Cost-utility analysis, cost-effectiveness analysis, cost minimization analysis

  • Within-RCT

  • Dutch societal

  • Time horizon: start of treatment to 1 yr after the end of phototherapy (68.4 wk total)

  • No discount

  • Adults with psoriasis who were clinically eligible for NB-UVB

  • Total N = 105

  • Average age: 41.2 (home), 45 (outpatient clinic)

  • Male (67%)

  • Intervention: home NB-UVB

  • Comparator: outpatient clinic NB-UVB

 QALYs

  • Home: 1.153

  • Outpatient clinic: 1.126

  • Incremental: 0.027



No. days with a relevant treatment effectb

  • Home: 216.5

  • Outpatient clinic: 210.4

  • Incremental: 6.1

  • Home: €1,272

  • Outpatient clinic: €1,148

  • Incremental: €124

  • €4,646 per QALY gained

  • €20.50 per additional day with relevant treatment effect

Abbreviations: NB-UVB, narrowband ultraviolet B phototherapy; No., number; QALY, quality-adjusted life year; RCT, randomized controlled trial.

a

All costs reported in 2003 Euro.

b

Defined in the study as achieving at least 50% reduction (improvement) from the baseline psoriasis area and severity index (PASI).